References

Bai, P., K. Phua, T. Harrdt, M. Cernadas and B. Brodsky, 1992. Glycation alters collagen fibril organization. Connect Tissues Res., 28: 1-12.
PubMed  |  

Brenner, B.M., M.E. Cooper, W.D. de Zeeu, W.F. Keane W.E. Mitch and H.H. Parving et al., 2001. Effects of losartan on renal and Cardiovascular outcomes in patients with type-2 diabetes and nephropathy. N. Engl. J. Med., 345: 861-869.
PubMed  |  Direct Link  |  

Brownlee, M., 2001. Biochemistry and molecular cell biology of diabetic complications. Nature, 414: 813-820.
CrossRef  |  PubMed  |  Direct Link  |  

Brownlee, M., 2005. The pathology of diabetic complications: A unifying mechanism. Diabetes, 54: 1615-1625.
PubMed  |  Direct Link  |  

Bucciarelli, L.G., T. Wendt, W. Qu, Y. Lu and E. Lalla et al., 2002. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation, 106: 2827-2835.

Dominicza, K.H., 2003. Obesity, glucose intolerance and diabetes and their links to cardiovascular diseases: Implications for laboratory medicine. Clin. Chem. Lab. Med., 41: 1266-1278.
Direct Link  |  

Forbers, J.M., G. Soldatos and C.T. Merilin, 2005. Advanced glycation end products that detour around the side Is HbAIC not an accurate enough predictor of long term progression and glyceamic control in diabetes?. Clin. Biochem. Rev., 26: 123-134.
PubMed  |  

Fu, M.X., K.J. Wells-knecht, J.A. Blacktedge, T.J. Lyons, S.R. Thorpe and J.W. Baynes, 1994. Glycation, glycoxidation and cross�linking of collagen by glucose: Kinetics, mechanisms and inhibition of late stages of the maillard reaction. Diabetes, 43: 676-683.
Direct Link  |  

Fu, M.X., K.J. Wells�Knecht, J.A. Balckledge, T.J. Lyons, S.R.T. Herpe and J.W. Bynes, 2004. The maillard or browning reactions between sygar and protein contributes to the increased chemical modification and cross linking of long�lived protein in diabetes. Diabetes, 43: 676-683.

Giacomoni, P.U., L. Declercq, L. Hellemans and D. Maes, 2000. Aging of human skin. Review of a mechanistic model and first experimental data. IUBMB Life, 49: 259-263.
Direct Link  |  

Hartog, J.W., A.P. de Vries, H.L. Lutgers, R. Meerwaldt and R.M. Huisman et al., 2005. Accumulation of Advanced glycation and products, measured as skin autofluorescence, in renal disease. Ann. N.Y. Acad. Sci., 1043: 299-307.
PubMed  |  

Hodge, J., 1953. Dehydrated foods: Chemistry of browning reaction in model systems. J. Agric. Food Chem., 1: 928-943.
Direct Link  |  

Kim, D.N., Y.S. Clin, K.H. Son, H.W. Chang, J.S. Kim, S.S. Kang and H.P. Kim, 2002. Effects of sophoraflavaone G, a prenylated flavonoid from sophora Flavescens, on cyclooxygenase-2 and In Vivo inflammatory response. Arch. Pharm. Res., 25: 329-335.
Direct Link  |  

Koslchinsky, T., C.J. He, T. Mitsuhashi, R. Bucala and C. Liu et al., 1997. Orally absorbed reactive glycation products (glycotoxins): An environment risk factors in diabetic neptropathy. Nat. Acad. Sci., 94: 6474-6479.
Direct Link  |  

Maillard, L., 1912. Action des acids amines surles sucress for mation des melanoiclines par voie methoehique. C.R. Acad. Sci., 154: 66-68.

Martin, A., M.R. Komada and D.C. Sane, 2003. Abnormal angiogenesion in diabetes mellitus. Med. Res. Rav., 23: 117-145.
PubMed  |  

Mogensen, C.E., S. Neldam, I. Tikkanen, S. Oren, R. Viskoper, R.W. Watts and M.E. Cooper, 2000. Randemised controlled trial of dual blockade of rennin�angiotensin system in patients in patients with hypertension, micro albuminuira, and non-insulin dependent diabetes: the candesartan and lisriopril micro albuminuria (CALM) study. BMJ, 321: 1440-1444.
Direct Link  |  

Nathan, D.M., J. Lachin, P. Cleary, T. Orchard and D.J. Brillon et al., 2003. Internsive diabetes therapy and carotid intima-media thickness in type-I diabetes mellitus. N. Engl. J. Med., 348: 2294-2303.
PubMed  |  

Pinnell, S.R., 2003. Cutameous photo-damage, oxdative stress and topical anti-oxidant protection. J. Am. Acad. Dermatol., 48: 1-9.
PubMed  |  

Soulis, T., V. Thallas, S. Yousef and R.E. Giberst, 1997. Advanced glycation end products and the receptor for advanced glycated end products colalise in organs susceptible to diabetic microvascular mjury: Immuno histochemical studies. Diabetologic, 40: 614-628.

Szweda, P.A., B. Foiguet and L.I. Szweda, 2002. Proteolysis, free radicals and aging. Free Radic. Biol. Med., 33: 29-36.
CrossRef  |  PubMed  |  

Thornalley, P.J., A. Langbory and H.S. Minhas, 1999. Formation of glyoxal methyglyoxal and 3�deoxyglucosone in the glycation of proteins by glucose. Biochem. J., 344: 109-116.
PubMed  |  

Thornalley, P.J., M. Westwood, T.W. LO and A.C. McLellan, 1995. Formation of methylglyoxal�modified proteins in vitro and in vivo and their involvement in AGE�related processes. Contrib. Nephrol., 112: 24-31.
PubMed  |  

Topol, E. and R.M. Califf, 2006. Textbook of Cardiovascular Medicine. Lippincott Williams and Wilkins, USA.

Valssara, H., 2001. The AGE�receptor in the pathogenesis of diabetic complications. Diabetes Metab. Res. Rev., 17: 436-443.
Direct Link  |  

Watson, R.E., S.G. Ball, N.M. Craven, J. Boorsma and C.L. East et al., 2001. Distribution and expression of type IV collagen in photoged skin. Br. J. Dermatol., 144: 751-759.
PubMed  |  

Yan, H.D., X.Z. Li, J.M. Xie and M. Li, 2007. Effects of advanced glycation end products on renal fibrosis and oxidative stress in culture. Clin. Med. J., 120: 787-793.
Direct Link  |